Search results
Decoding VICI Properties Inc (VICI): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 36 minutes agoRobust revenue growth and solid net income performance in Q1 2024. Strategic acquisitions and...
Decoding CVS Health Corp (CVS): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 38 minutes agoCVS Health Corp demonstrates robust revenue growth in its Premiums and Services segments. Despite a...
Decoding Neurocrine Biosciences Inc (NBIX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 37 minutes agoNeurocrine Biosciences Inc showcases robust revenue growth and operational efficiency. Strategic...
Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 37 minutes agoUnited Therapeutics Corp showcases robust revenue growth and solid operational performance....
Decoding Mastercard Inc (MA): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 40 minutes agoMastercard Inc showcases robust revenue growth and net income increase in recent quarterly results....
Decoding Principal Financial Group Inc (PFG): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 40 minutes agoPrincipal Financial Group Inc (NASDAQ:PFG) showcases robust revenue growth and a strong balance...
Decoding Arthur J. Gallagher & Co (AJG): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 40 minutes agoArthur J. Gallagher & Co's robust brokerage segment continues to drive revenue growth. Strategic...
Decoding Equity Lifestyle Properties Inc (ELS): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 38 minutes agoELS showcases robust revenue growth, with a notable increase in rental income and comprehensive...
Earnings call: Bio-Techne sees growth in Q3 with strong market positioning
Investing.com· 43 minutes agoBio-Techne (NASDAQ: TECH ) Corporation ( NASDAQ : TECH) reported a 2% year-over-year organic revenue...
GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 39 minutes agoProfit margin: 14% (down from 21% in 1Q 2023). EPS: UK£0.26 (down from UK£0.37 in 1Q 2023). LSE:GSK...